Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 6:26 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-24 | Payment of Exercise | 4,187 | $6.18 | $25,854.70 | (2%) 229.62K to 225.43K | |
| 17-May-24 7:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-May-24 | Payment of Exercise | 867 | $10.01 | $8,678.67 | (< 1%) 244.63K to 243.76K | |
| 13-Feb-24 7:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Grant | 55,808 | -- | -- | 29% 190.71K to 246.52K | |
| 13-Feb-24 7:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Payment of Exercise | 1,892 | $10.09 | $19,090.30 | (< 1%) 246.52K to 244.63K | |
| 07-Jun-23 7:36 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jun-23 | Grant | 190,713 | -- | -- | 100% 0 to 190.71K | |
| 06-Oct-21 6:02 PM View: | Prelude Therapeutics Inc (PRLD) | 05-Oct-21 | Option Exercise | 15,000 | $1.89 | $28,350.00 | 100% 0 to 15.0K | |
| 06-Oct-21 6:02 PM View: | Prelude Therapeutics Inc (PRLD) | 05-Oct-21 | Market Option Sale (Planned) | 15,000 | $30.96 | $464,350.00 | (100%) 15.0K to 0 | |
| 09-Sep-21 10:00 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Sep-21 | Option Exercise | 15,000 | $1.89 | $28,350.00 | 100% 0 to 15.0K | |
| 09-Sep-21 10:00 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Sep-21 | Market Option Sale (Planned) | 15,000 | $36.69 | $550,283.00 | (100%) 15.0K to 0 | |
| 09-Aug-21 4:26 PM View: | Prelude Therapeutics Inc (PRLD) | 05-Aug-21 | Option Exercise | 15,000 | $1.89 | $28,350.00 | 100% 0 to 15.0K | |
| 09-Aug-21 4:26 PM View: | Prelude Therapeutics Inc (PRLD) | 05-Aug-21 | Market Option Sale (Planned) | 15,000 | $31.09 | $466,394.00 | (100%) 15.0K to 0 | |
| 08-Jul-21 5:41 PM View: | Prelude Therapeutics Inc (PRLD) | 06-Jul-21 | Option Exercise | 15,000 | $1.89 | $28,350.00 | 100% 0 to 15.0K | |
| 08-Jul-21 5:41 PM View: | Prelude Therapeutics Inc (PRLD) | 06-Jul-21 | Market Option Sale (Planned) | 15,000 | $27.47 | $412,107.00 | (100%) 15.0K to 0 | |
| 09-Jun-21 6:24 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Jun-21 | Option Exercise | 15,000 | $1.89 | $28,350.00 | 100% 0 to 15.0K | |
| 09-Jun-21 6:24 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Jun-21 | Market Option Sale (Planned) | 15,000 | $32.44 | $486,622.00 | (100%) 15.0K to 0 | |
| 10-May-21 4:37 PM View: | Prelude Therapeutics Inc (PRLD) | 05-May-21 | Option Exercise | 15,000 | $1.89 | $28,350.00 | 100% 0 to 15.0K | |
| 10-May-21 4:37 PM View: | Prelude Therapeutics Inc (PRLD) | 05-May-21 | Market Option Sale (Planned) | 15,000 | $40.14 | $602,092.00 | (100%) 15.0K to 0 | |
| 29-Apr-21 5:14 PM View: | Prelude Therapeutics Inc (PRLD) | 27-Apr-21 | Option Exercise | 25,000 | $1.89 | $47,250.00 | 100% 0 to 25.0K | |
| 29-Apr-21 5:14 PM View: | Prelude Therapeutics Inc (PRLD) | 27-Apr-21 | Market Option Sale (Planned) | 25,000 | $35.39 | $884,848.00 | (100%) 25.0K to 0 | |
| 21-Apr-21 7:56 PM View: | Prelude Therapeutics Inc (PRLD) | 19-Apr-21 | Option Exercise | 25,000 | $1.89 | $47,250.00 | 100% 0 to 25.0K | |
| 21-Apr-21 7:56 PM View: | Prelude Therapeutics Inc (PRLD) | 19-Apr-21 | Market Option Sale (Planned) | 25,000 | $30.89 | $772,349.00 | (100%) 25.0K to 0 | |
| 15-Apr-21 7:09 PM View: | Prelude Therapeutics Inc (PRLD) | 08-Apr-21 | Option Exercise | 9,617 | $1.89 | $18,176.10 | 100% 0 to 9.62K | |
| 15-Apr-21 7:09 PM View: | Prelude Therapeutics Inc (PRLD) | 08-Apr-21 | Market Option Sale (Planned) | 9,617 | $38.35 | $368,852.00 | (100%) 9.62K to 0 | |
| 09-Apr-21 5:50 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Apr-21 | Option Exercise | 15,383 | $1.89 | $29,073.90 | 100% 0 to 15.38K | |
| 09-Apr-21 5:50 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Apr-21 | Market Option Sale (Planned) | 15,383 | $39.33 | $605,023.00 | (100%) 15.38K to 0 | |
| 04-Jan-16 4:30 PM View: | Advaxis Inc. (ADXS) | 31-Dec-15 | Grant | 195 | $10.06 | $1,961.70 | < 1% 166.12K to 166.31K | (100%) |
| 04-Jan-16 4:30 PM View: | Advaxis Inc. (ADXS) | 31-Dec-15 | Payment of Exercise | 41 | $10.06 | $412.46 | (< 1%) 166.31K to 166.27K | 100% |
| 01-Dec-15 4:31 PM View: | Advaxis Inc. (ADXS) | 30-Nov-15 | Grant | 108 | $12.07 | $1,303.56 | < 1% 166.03K to 166.14K | (100%) |
| 01-Dec-15 4:31 PM View: | Advaxis Inc. (ADXS) | 30-Nov-15 | Payment of Exercise | 18 | $12.07 | $217.26 | (< 1%) 166.14K to 166.12K | 100% |
| 03-Nov-15 4:31 PM View: | Advaxis Inc. (ADXS) | 30-Oct-15 | Grant | 117 | $11.09 | $1,297.53 | < 1% 165.93K to 166.05K | (100%) |
| 03-Nov-15 4:31 PM View: | Advaxis Inc. (ADXS) | 30-Oct-15 | Payment of Exercise | 21 | $11.09 | $232.89 | (< 1%) 166.05K to 166.03K | 100% |
| 22-Oct-15 4:30 PM View: | Advaxis Inc. (ADXS) | 20-Oct-15 | Market Sale | 24,586 | $10.08 | $247,827.00 | (13%) 190.52K to 165.93K | 100% |
| 01-Oct-15 4:32 PM View: | Advaxis Inc. (ADXS) | 30-Sep-15 | Grant | 127 | $10.23 | $1,299.21 | < 1% 190.41K to 190.54K | (100%) |
| 01-Oct-15 4:32 PM View: | Advaxis Inc. (ADXS) | 30-Sep-15 | Payment of Exercise | 23 | $10.23 | $235.29 | (< 1%) 190.54K to 190.52K | 100% |
| 02-Sep-15 4:32 PM View: | Advaxis Inc. (ADXS) | 31-Aug-15 | Grant | 88 | $14.80 | $1,302.40 | < 1% 190.34K to 190.43K | (100%) |
| 02-Sep-15 4:32 PM View: | Advaxis Inc. (ADXS) | 31-Aug-15 | Payment of Exercise | 16 | $14.80 | $236.80 | (< 1%) 190.43K to 190.41K | 100% |
| 04-Aug-15 4:31 PM View: | Advaxis Inc. (ADXS) | 31-Jul-15 | Grant | 117 | $16.66 | $1,949.22 | < 1% 190.25K to 190.37K | (100%) |
| 04-Aug-15 4:31 PM View: | Advaxis Inc. (ADXS) | 31-Jul-15 | Payment of Exercise | 25 | $16.66 | $416.50 | (< 1%) 190.37K to 190.34K | 100% |
| 01-Jul-15 4:32 PM View: | Advaxis Inc. (ADXS) | 30-Jun-15 | Grant | 64 | $20.33 | $1,301.12 | < 1% 190.2K to 190.26K | (100%) |
| 01-Jul-15 4:32 PM View: | Advaxis Inc. (ADXS) | 30-Jun-15 | Payment of Exercise | 12 | $20.33 | $243.96 | (< 1%) 190.26K to 190.25K | 100% |
| 02-Jun-15 4:31 PM View: | Advaxis Inc. (ADXS) | 29-May-15 | Grant | 51 | $25.16 | $1,283.16 | < 1% 190.16K to 190.21K | (100%) |
| 02-Jun-15 4:31 PM View: | Advaxis Inc. (ADXS) | 29-May-15 | Payment of Exercise | 9 | $25.16 | $226.44 | (< 1%) 190.21K to 190.2K | 100% |
| 01-May-15 4:31 PM View: | Advaxis Inc. (ADXS) | 30-Apr-15 | Grant | 76 | $16.81 | $1,277.56 | < 1% 190.09K to 190.17K | (100%) |
| 01-May-15 4:31 PM View: | Advaxis Inc. (ADXS) | 30-Apr-15 | Payment of Exercise | 13 | $16.81 | $218.53 | (< 1%) 190.17K to 190.16K | 100% |
| 01-Apr-15 6:06 PM View: | Advaxis Inc. (ADXS) | 31-Mar-15 | Grant | 85 | $14.44 | $1,227.40 | < 1% 190.05K to 190.13K | (100%) |
| 01-Apr-15 6:06 PM View: | Advaxis Inc. (ADXS) | 31-Mar-15 | Payment of Exercise | 38 | $14.44 | $548.72 | (< 1%) 190.13K to 190.09K | 100% |
| 01-Apr-15 6:06 PM View: | Advaxis Inc. (ADXS) | 30-Mar-15 | Grant | 55,110 | -- | -- | 39% 141.0K to 196.11K | |
| 01-Apr-15 6:06 PM View: | Advaxis Inc. (ADXS) | 30-Mar-15 | Payment of Exercise | 6,062 | $13.44 | $81,473.30 | (3%) 196.11K to 190.05K | 100% |
| 02-Mar-15 4:30 PM View: | Advaxis Inc. (ADXS) | 27-Feb-15 | Grant | 136 | $9.00 | $1,224.00 | < 1% 140.89K to 141.03K | (100%) |
| 02-Mar-15 4:30 PM View: | Advaxis Inc. (ADXS) | 27-Feb-15 | Payment of Exercise | 32 | $9.00 | $288.00 | (< 1%) 141.03K to 141.0K | 100% |